Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Opiant Pharmaceuticals Inc (OPNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,104
  • Shares Outstanding, K 2,070
  • Annual Sales, $ 18,450 K
  • Annual Income, $ 6,580 K
  • 36-Month Beta -2.02
  • Price/Sales 2.31
  • Price/Cash Flow 6.34
  • Price/Book 1,049.51
  • Price/Earnings ttm 49.05
  • Earnings Per Share ttm 0.42
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/15/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-1000 Metal Mining

    Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.56 +5.62%
on 01/23/18
25.52 -19.06%
on 12/26/17
-4.29 (-17.19%)
since 12/22/17
3-Month
17.01 +21.46%
on 12/19/17
48.00 -56.96%
on 10/26/17
-10.14 (-32.92%)
since 10/23/17
52-Week
5.00 +313.20%
on 06/16/17
51.90 -60.19%
on 09/08/17
+12.86 (+164.87%)
since 01/23/17

Most Recent Stories

More News
Opiant Pharmaceuticals Receives Approximately $5.3 Million of Cash from Exercise of Outstanding Warrants

Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced the receipt of approximately $5.3 million...

OPNT : 20.66 (+1.57%)
Insider Q&A: Narcan exec talks merits of spray for overdoses

NEW YORK (AP) — Dr. Roger Crystal's company was struggling to find new uses for an old drug that reverses overdoses. Then the opioid epidemic hit.

OPNT : 20.66 (+1.57%)
Opiant Pharmaceuticals Announces Significant Financial Developments Related to NARCAN(R) Nasal Spray for Opioid Overdose

Opiant Expects to Receive 90% of NARCAN Sales-Related Royalty and Milestone Payments, Going Forward

OPNT : 20.66 (+1.57%)
Opiant Pharmaceuticals (Nasdaq: OPNT) to Ring The Nasdaq Stock Market Opening Bell

What:

OPNT : 20.66 (+1.57%)
NDAQ : 80.21 (-0.52%)
Opiant Pharmaceuticals Announces Publication of New Pre-Clinical Data Supporting Potential of OPNT005 as a Heroin Vaccine

Data Published Online in Journal of Medicinal Chemistry

OPNT : 20.66 (+1.57%)
Opiant Pharmaceuticals, Inc. Reports Fiscal First Quarter 2018 Financial Results

Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported financial results for the fiscal first quarter...

OPNT : 20.66 (+1.57%)
Opiant Pharmaceuticals, Inc. Reports Fiscal Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported financial results for the fiscal fourth quarter...

OPNT : 20.66 (+1.57%)
Corporate News Blog - Titan Pharma and Opiant Pharma Collaborate to Discover a New Approach for Treatment of Opioid Use Disorder

LONDON, UK / ACCESSWIRE / October 4, 2017 / Pro-Trader Daily looks at the latest corporate events and news making the headlines for Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), following which we have published...

OPNT : 20.66 (+1.57%)
TTNP : 1.42 (+5.56%)
Opiant Pharmaceuticals and Titan Pharmaceuticals Collaborate to Explore a New Approach to Opioid Use Disorder Treatment

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) and Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) today announced a collaboration to explore development of a novel approach to the prevention of opioid relapse and...

OPNT : 20.66 (+1.57%)
TTNP : 1.42 (+5.56%)
Titan Pharmaceuticals and Opiant Pharmaceuticals Collaborate to Explore a New Approach to Opioid Use Disorder Treatment

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) and Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) today announced a collaboration to explore development of a novel approach to the prevention of opioid relapse and...

OPNT : 20.66 (+1.57%)
TTNP : 1.42 (+5.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. Opiant Pharmaceuticals Inc., formerly known as Lightlake Therapeutics, Inc., is based in New York.

See More

Key Turning Points

2nd Resistance Point 21.89
1st Resistance Point 21.27
Last Price 20.66
1st Support Level 19.80
2nd Support Level 18.95

See More

52-Week High 51.90
Fibonacci 61.8% 33.98
Fibonacci 50% 28.45
Fibonacci 38.2% 22.92
Last Price 20.66
52-Week Low 5.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.